Objectives COVID-19 causes lung parenchymal and endothelial damage that lead to hypoxic acute respiratory failure (hARF). The influence of hARF severity on patients’ outcomes is still poorly ...
1 Jozef Strus Municipal Hospital, Department of Rheumatology and Osteoporosis, Poznan, Poland 2 Poznan University of Medical Sciences, Department of Rheumatology, Rehabilitation and Internal Diseases, ...
Douglas Kondo, MD, Associate Professor (Clinical), is an adult and child psychiatrist, and brain imaging researcher who works at the Salt Lake City VA Healthcare System (SLCVAHCS), in the Rocky ...
The SOFA-2 score included new definitions, new variables, and revised thresholds to categorize the severity of organ dysfunction in critical illness. The updates reflected changes in practice, ...
ABSTRACT: Background: There is a paucity of data on the efficacy of ventilatory strategies in COVID-19-related ARDS. The aim of this study was to describe the effect of positive end-expiratory ...
Clinical question: Do the anti-inflammatory and immunomodulatory effects of glucocorticoids decrease mortality among patients with severe community-acquired pneumonia (CAP)? Background: CAP remains a ...
ABSTRACT: Importance: The best respiratory support technique to reduce intubation and mortality in patients with respiratory failure due to COVID-19 is controversial. Objective: To determine the ...
The PF ratio (PaO2/FiO2 ratio) is an essential indicator used in medicine to gauge the severity of a patient’s hypoxemic respiratory failure. This value helps healthcare professionals determine ...
Calculating the partial pressure of oxygen in arterial blood (PaO2) is an essential skill for medical professionals, especially in assessing a patient’s respiratory health. This article will provide a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results